Overexpression of cyclin D1 and cyclin E in 1,2-dimethylhydrazine dihydrochloride-induced rat colon carcinogenesis

K Hur1, J R Kim, B I Yoon

  • 1Department of Veterinary Pathology, College of Veterinary Medicine and School of Agricultural Biotechnology, Seoul National University, Suwon, 441-744, Korea.

Insights

Overexpression of cyclin D1 and cyclin E in rat colon tumors suggests their early involvement in cancer development. These G1 cyclins may disrupt cell-cycle control during early stages of colon carcinogenesis and tumor progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • Deregulation of G1 cyclins is implicated in various cancers, including colon cancer.
  • Understanding G1 cyclin expression is crucial for unraveling colon carcinogenesis mechanisms.

Purpose of the Study:

  • To investigate the expression patterns of cyclin D1 and cyclin E in 1,2-dimethylhydrazine dihydrochloride (DMH)-induced rat colon carcinogenesis.
  • To assess the role of these G1 cyclins in the multistage process of colon tumor development.

Main Methods:

  • Quantitative reverse transcription-polymerase chain reaction (RT-PCR) for mRNA analysis.
  • Immunohistochemistry (IHC) for protein expression analysis.
  • Utilized DMH-induced rat model for colon carcinogenesis.

Main Results:

  • Cyclin E mRNA levels significantly increased in both adenomas and adenocarcinomas.
  • Cyclin D1 mRNA levels showed a significant increase only in adenocarcinomas.
  • Both cyclin D1 and cyclin E proteins were overexpressed in neoplastic cells of adenomas and adenocarcinomas.

Conclusions:

  • Overexpression of cyclin D1 and cyclin E occurs early in rat colon carcinogenesis, potentially impacting cell-cycle control.
  • These G1 cyclins may play a significant role in both the initiation and progression of colon tumors.
  • Findings highlight the importance of G1 cyclins in multistage colon carcinogenesis.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...